anmelden
FTSE All-Share
5.563,81
PKT
+23,96
PKT
+0,43
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.01.23 | HSBC Buy | Jefferies & Company Inc. | |
| 06.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 06.01.23 | Glencore Buy | Jefferies & Company Inc. | |
| 06.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 06.01.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 05.01.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 05.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.01.23 | GSK Hold | Jefferies & Company Inc. | |
| 05.01.23 | HSBC Buy | Jefferies & Company Inc. | |
| 05.01.23 | Glencore Outperform | Credit Suisse Group | |
| 04.01.23 | Diageo Outperform | Credit Suisse Group | |
| 04.01.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.01.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.12.22 | Diageo Buy | Goldman Sachs Group Inc. | |
| 23.12.22 | AstraZeneca Overweight | Barclays Capital | |
| 23.12.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 23.12.22 | GSK Equal Weight | Barclays Capital | |
| 21.12.22 | HSBC Outperform | RBC Capital Markets | |
| 21.12.22 | BAT Neutral | Goldman Sachs Group Inc. | |
| 20.12.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 20.12.22 | BP Hold | Jefferies & Company Inc. | |
| 20.12.22 | Diageo Buy | Jefferies & Company Inc. | |
| 19.12.22 | Diageo Overweight | JP Morgan Chase & Co. | |
| 19.12.22 | BAT Overweight | JP Morgan Chase & Co. | |
| 19.12.22 | Unilever Underweight | JP Morgan Chase & Co. | |
| 19.12.22 | Diageo Market-Perform | Bernstein Research | |
| 16.12.22 | National Grid Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | Barclays Buy | Goldman Sachs Group Inc. | |
| 15.12.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.12.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.12.22 | Diageo Outperform | Credit Suisse Group | |
| 14.12.22 | BP Outperform | RBC Capital Markets | |
| 14.12.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 14.12.22 | Diageo Sell | Deutsche Bank AG | |
| 14.12.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.12.22 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 14.12.22 | Glencore Overweight | JP Morgan Chase & Co. |